Literature DB >> 26967463

Amyloid-β and α-Synuclein Decrease the Level of Metal-Catalyzed Reactive Oxygen Species by Radical Scavenging and Redox Silencing.

Jeppe T Pedersen, Serene W Chen1, Christian B Borg2, Samuel Ness1, Justyna M Bahl3,4, Niels H H Heegaard3,4, Christopher M Dobson1, Lars Hemmingsen, Nunilo Cremades1,5, Kaare Teilum2.   

Abstract

The formation of reactive oxygen species (ROS) is linked to the pathogenesis of neurodegenerative diseases. Here we have investigated the effect of soluble and aggregated amyloid-β (Aβ) and α-synuclein (αS), associated with Alzheimer's and Parkinson's diseases, respectively, on the Cu(2+)-catalyzed formation of ROS in vitro in the presence of a biological reductant. We find that the levels of ROS, and the rate by which ROS is generated, are significantly reduced when Cu(2+) is bound to Aβ or αS, particularly when they are in their oligomeric or fibrillar forms. This effect is attributed to a combination of radical scavenging and redox silencing mechanisms. Our findings suggest that the increase in ROS associated with the accumulation of aggregated Aβ or αS does not result from a particularly ROS-active form of these peptides, but rather from either a local increase of Cu(2+) and other ROS-active metal ions in the aggregates or as a downstream consequence of the formation of the pathological amyloid structures.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26967463      PMCID: PMC4827876          DOI: 10.1021/jacs.5b13577

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


A hallmark of the two major neurodegenerative disorders, Alzheimer’s disease (AD) and Parkinson’s disease (PD), is the deposition within the brain of the amyloid β peptide (Aβ) and α-synuclein (αS), respectively.[1] Despite the difference in the specific protein found to be the main component of the amyloid deposits in AD and PD, the formation of the pathological aggregates appears to occur via a common misfolding and self-assembly process.[1] The cytotoxic species involved in both diseases appear to be the soluble oligomeric intermediates that form during the process of amyloid formation. Although the precise mechanism responsible for the toxicity of such species is not fully established, increasing evidence suggests that the neuronal cell loss in AD and PD is at least in part linked to excessive free radical generation.[2] Aβ and αS bind metal ions, including Cu2+, that promote oligomerization and amyloid formation by both polypeptides[3−5] and catalyze the formation of reactive oxygen species (ROS) that cause oxidative damage. In the brains of both AD and PD patients, increased oxidative damage, including protein, DNA, and RNA oxidation and lipid peroxidation, is observed relative to healthy controls.[6−8] Impaired copper and iron homeostasis has also been associated with AD and PD, with elevated levels of both metals being found in the senile plaques from AD patients and in the Lewy bodies and cerebrospinal fluid of PD patients,[9−11] which has stimulated interest in understanding the interaction of Aβ and αS with metal ions and its implications in AD and PD. The coordination of Cu2+ to soluble Aβ and αS has been characterized in atomic detail. In Aβ, Cu2+ is primarily coordinated to Asp1, His6, His13, and His14 at physiological pH.[12,13] In αS, a high affinity binding site has been identified, involving the first nine residues at the N-terminus.[14,15] This binding site is, however, inactivated when the N-terminus is acetylated,[16] but two low affinity binding sites in the vicinity of residues His50 and Asp121 bind Cu2+ in the acetylated form of αS found in vivo.[16−18] It has been proposed that Cu2+ coordinated to Aβ and αS, in the presence of physiological reductants such as ascorbate, catalyzes the reduction of molecular oxygen to H2O2 and hydroxyl radicals (HO•) via Fenton chemistry (Figure ). The coordination of Cu+ is different from that of Cu2+ for both Aβ and αS. In Aβ, Cu+ is only coordinated to His13 and His14,[13] and in αS, it is primarily coordinated to the side chains of Met1, Asp2, and Met5.[19] Thus, the change in the oxidation state of Cu during the Fenton reaction cycle will induce structural changes in the protein–Cu complexes. The more ordered aggregated states of Aβ and αS may shift the energy difference between the Cu+ and the Cu2+ complexes relative to the flexible monomeric states and potentially influence the kinetics of ROS formation.
Figure 1

Fenton reaction cycle for the production of ROS from molecular oxygen and ascorbate (Asc); see ref (20)

Fenton reaction cycle for the production of ROS from molecular oxygen and ascorbate (Asc); see ref (20) Here we have explored how the Cu2+ interaction with different aggregated states of Aβ and αS affect ROS production in the presence of 100 μM ascorbate. We used a 2:1 protein/Cu2+ molar ratio to avoid the presence of free Cu2+ in solution. No detectable ROS production was observed in the samples without the addition of Cu2+ and ascorbate (Figure S1). We measured the production of both H2O2 and HO• with colorimetric and fluorescence assays and also followed the consumption of ascorbate as a direct assay of ROS production. Aβ40 and αS were studied, along with variants deficient in the ability of bind Cu2+, namely, Aβ40[H6A/H13A/H14A], where the Cu2+-coordinating histidine residues in Aβ were all substituted by alanine, and αSΔ2–9, where residues 2–9 in αS were deleted. Aggregated Aβ and αS fibrils were prepared both in the absence and presence of Cu2+. In addition, αS oligomeric species with structural features that are intermediate between the intrinsically disordered monomeric protein and the highly organized mature fibrils[21] were included in the analysis. These oligomeric forms of αS induce ROS production when internalized in healthy neuronal cells.[21,22] The mechanism of αS-oligomer-induced ROS production has been linked to the presence of free metal ions in the culture media.[23] The rates and the levels of ROS production were highly dependent on which form of Aβ or αS was present in the solution. In the absence of protein, all ascorbate was consumed within approximately 10 min (Figure A,B). The presence of Aβ40[H6A/H13A/H14A], which does not bind Cu2+, had no effect on the ascorbate consumption rate (Figure S2A). Only very small effects on ascorbate consumption were seen on addition of monomeric and oligomeric αSΔ2–9 to the Cu2+/ascorbate reaction mixture (Figure S2B). The rate of ascorbate consumption, however, decreased 2- to 3-fold when Cu2+ was bound to soluble wt-Aβ40 or wt-αS. The rate was reduced even more (5-fold) when Cu2+ was bound to either oligomeric or fibrillar states of Aβ40 and αS (Figures A,B and S3). The most pronounced effects were monitored for Aβ40 and αS fibrils that were formed in the presence of Cu2+, which produced ROS at a rate decreased nearly 20-fold relative to that for the same concentration of free metal ions in solution (Figures A,B and S3). Even for αSΔ2–9, the fibrils formed in the presence of Cu2+ reduced the rate of ascorbate consumption more than any other αSΔ2−9 species (Figure S2).
Figure 2

Generation of ROS in the presence of Aβ40 and αS. (A and B) Consumption of ascorbate, measured by the decrease in absorbance at 265 nm, for (A) Aβ40 and (B) αS. (C and D) Generation of H2O2, measured by the increase in resorufin fluorescence at 590 nm, for (C) Aβ40 and (D) αS. (E and F) The formation of HO• was measured by the increase in fluorescence at 450 nm upon oxidation of 3-CCA for (E) Aβ40 and (F) αS. Seven different conditions were employed (red, monomeric protein; black, fibrils formed in the absence of Cu2+; gray, fibrils formed in the presence of Cu2+; blue, oligomers (αS only); purple, Cu2+ alone; orange, ascorbate alone; and green, Cu2+ and ascorbate alone). In all assays, the concentrations of protein, Cu2+, and ascorbate were 10, 5, and 100 μM, respectively.

Generation of ROS in the presence of Aβ40 and αS. (A and B) Consumption of ascorbate, measured by the decrease in absorbance at 265 nm, for (A) Aβ40 and (B) αS. (C and D) Generation of H2O2, measured by the increase in resorufin fluorescence at 590 nm, for (C) Aβ40 and (D) αS. (E and F) The formation of HO• was measured by the increase in fluorescence at 450 nm upon oxidation of 3-CCA for (E) Aβ40 and (F) αS. Seven different conditions were employed (red, monomeric protein; black, fibrils formed in the absence of Cu2+; gray, fibrils formed in the presence of Cu2+; blue, oligomers (αS only); purple, Cu2+ alone; orange, ascorbate alone; and green, Cu2+ and ascorbate alone). In all assays, the concentrations of protein, Cu2+, and ascorbate were 10, 5, and 100 μM, respectively. The formation of H2O2 (Figure C,D) closely followed the consumption of ascorbate and reached the same level for all states of the proteins. In contrast, not only the rate but also the final levels of HO• varied between the samples, with lower rates being associated with lower final levels of the radical (Figure E,F). Fibrils of Aβ40 completely abolished the generation of free HO• species that could react with 3-CCA. In addition, the fibrils of αS that were formed in the presence of Cu2+ resulted in very low levels of free HO•. Moreover, in the presence of Cu2+, the oligomers of αS lowered the level of HO• to the same extent as that of fibrils of αS formed in the absence of Cu2+ (compare Figure F blue and gray curves). Together, the data suggest that Cu2+ is less accessible to the solvent when bound to the aggregated forms of Aβ40 and αS than when bound to the monomeric state, and much less than when free in solution; hence, it is less able to react with ascorbate, resulting in slower ROS formation. Although all ascorbate was consumed and the same levels of H2O2 were produced at the end of the reaction under all conditions, significant differences in the amount of free HO• were observed, which correlates with the variations in the initial rate of ROS production by the different protein species. This observation suggests that the proteins act as efficient scavengers of HO• produced by Cu2+–protein complexes. Oxidation effects detected by mass spectrometry. Samples were measured after 30 min incubation in the presence of 100 μM ascorbate. (A and B) Monomers (red) and fibrils (black) of Aβ40. (C and D) Monomers (red), oligomers (blue), and fibrils (black) of αS. Panels B and D are expansions of the main peaks in panel A and C, respectively. The Cu concentration in all samples was 5 μM. To confirm that the proteins do indeed act as radical scavengers and to characterize the covalent modifications of Aβ40 and αS induced by the oxidation, we monitored the time-dependent changes in molecular mass using MALDI-TOF MS (Figures and S4). In the presence of Cu2+ and ascorbate, we observed a low level of oxidation and cleavage of αS. The oxidative patterns for monomeric, oligomeric, and fibrillar states of αS are similar to each other, although the monomer demonstrates a slightly higher level of oxidation (Figure D). More oxidation and oxidation-driven cleavage of the polypeptide chain are evident for Aβ40. Here, an intense peak in the mass spectrum corresponding to cleavage of the peptide backbone between the Cu2+ coordination residues His13 and His14 appears within the first 30 min of the redox reaction (Figure B), in agreement with previous observations.[24,25] More oxidation is observed for monomeric Aβ40 than for αS, consistent with the results from the 3-CCA assay, which show that the level of free HO• is lower in the Aβ40 samples than in the corresponding αS samples and that Aβ thus more readily reacts with HO• (compare Figure E,F). Our results, therefore, indicate that Aβ40 is more efficient than αS as an HO• scavenger.
Figure 3

Oxidation effects detected by mass spectrometry. Samples were measured after 30 min incubation in the presence of 100 μM ascorbate. (A and B) Monomers (red) and fibrils (black) of Aβ40. (C and D) Monomers (red), oligomers (blue), and fibrils (black) of αS. Panels B and D are expansions of the main peaks in panel A and C, respectively. The Cu concentration in all samples was 5 μM.

The slower ROS formation and lower free HO• levels in the presence of fibrils cannot be fully explained by the fibrils acting as more efficient ROS scavengers than the soluble species. If this were the case, then we would not expect the ascorbate consumption to be slowed down. Furthermore, we observe more oxidized species in the monomeric samples than in the fibrillar samples. The effect of the Aβ40 and αS fibrils, and αS oligomers, is rather to sequester Cu2+ from the solution and decrease the rate of Cu redox cycling. Aβ40 and αS have previously both been suggested to act as pro-oxidants,[14,20,26] and Aβ40 has also been suggested to act as an antioxidant.[27,28] The main argument for αS and Aβ40 acting as pro-oxidants is that higher levels of free radicals are produced when Cu2+ is bound to these proteins than when Cu2+ is bound to other peptides or proteins. In contrast, the main argument for Aβ40 acting as an antioxidant is that less free radicals are produced by Cu2+ bound to Aβ40 relative to those from free Cu2+. Here we have shown that both Aβ40 and αS, when bound to Cu2+, reduce the ROS levels as compared to free Cu2+. This reduction is likely to be related to the binding of Aβ40 and αS to Cu2+ because the ROS levels of Cu2+ in the presence of monomeric Aβ40[H6A/H13A/H14A] and αSΔ2–9 are very similar to those in the presence of free Cu2+ (Figure S2). We have also shown that the oligomeric and fibrillar samples of Aβ40 and αS are much more efficient than soluble species at reducing the HO• levels in solution. Our data show that Aβ40 and αS both serve as HO• scavengers, because they reduce the amount of free HO• in the solution, and that the binding of Cu2+ to the proteins decreases ROS production. These effects become more prominent when Cu2+ is bound to the β-sheet-rich conformations of the aggregates in both Aβ40 and αS. It is likely that the compact structure of the aggregates prevents accessibility of oxygen and ascorbate to Cu2+ and, therefore, suppresses electron transfer from the metal ions to oxygen molecules. This notion is supported by EPR and ESEEM data that suggest that the preferred Cu2+ coordination mode in both soluble and aggregated Aβ40 is unfavorable for Cu+/Cu2+ redox cycling.[29] As a consequence, ROS production mediated by Cu2+ will be decreased when Cu2+ is coordinated to Aβ40 and in particular when coordinated to Aβ40 fibrils. Furthermore, the decrease in redox activity in the aggregated state may reflect the fact that redox cycling of coordinated Cu+ and Cu2+ requires formation of a transient intermediate coordination state where the coordination sphere differs from the resting states of Aβ–Cu+/2+.[12] If the free energy barrier for formation of this transient state is increased in the aggregated species, e.g., as a result of a decrease in flexibility of the coordination sphere, then the redox activity of Cu2+ coordinated to aggregated Aβ40 or αS will decrease.[30] Formation of the transient intermediate state may be further inhibited by the increase in the number of Cu2+ coordination modes in the aggregates compared to the soluble proteins.[31] Using two different amyloidogenic proteins, we have demonstrated that Cu2+-catalyzed ROS formation is significantly reduced when the metal ion is bound to aggregated species, which also act as HO• scavengers. Although we and others have previously shown that certain amyloid aggregates such as those used in this study are able to induce more aberrant ROS production than are monomeric species when internalized in cells,[22,23,32] the in vitro data presented here reveal that this is likely not to be a consequence of direct ROS formation catalyzed by the aggregates but rather a downstream consequence of a primary effect of these aggregates on the cells. Nevertheless, some ROS is produced from Cu2+ bound to aggregates, and as a result of the high concentrations of amyloid species in plaques and Lewy bodies, ROS may increase locally in the regions of amyloid accumulation, although relative to Cu2+ that is freely diffusing or even bound to physiological forms of Aβ40 or αS, the aggregates will strongly attenuate the ROS formation.
  31 in total

Review 1.  Protein misfolding, functional amyloid, and human disease.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

Review 2.  Metals in Alzheimer's and Parkinson's diseases.

Authors:  Kevin J Barnham; Ashley I Bush
Journal:  Curr Opin Chem Biol       Date:  2008-04       Impact factor: 8.822

3.  Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.

Authors:  P Riederer; E Sofic; W D Rausch; B Schmidt; G P Reynolds; K Jellinger; M B Youdim
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

4.  Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Authors:  D T Dexter; C J Carter; F R Wells; F Javoy-Agid; Y Agid; A Lees; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

5.  Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.

Authors:  J Zhang; G Perry; M A Smith; D Robertson; S J Olson; D G Graham; T J Montine
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

6.  Cu(II)-catalyzed oxidation of beta-amyloid peptide targets His13 and His14 over His6: Detection of 2-Oxo-histidine by HPLC-MS/MS.

Authors:  Christian Schöneich; Todd D Williams
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

7.  Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state.

Authors:  Luc Guilloreau; Sarah Combalbert; Alix Sournia-Saquet; Honoré Mazarguil; Peter Faller
Journal:  Chembiochem       Date:  2007-07-23       Impact factor: 3.164

Review 8.  Biological metals and metal-targeting compounds in major neurodegenerative diseases.

Authors:  Kevin J Barnham; Ashley I Bush
Journal:  Chem Soc Rev       Date:  2014-08-07       Impact factor: 54.564

9.  Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1-10, 1-16 fragments of human and mouse beta-amyloid peptide.

Authors:  Teresa Kowalik-Jankowska; Monika Ruta; Kornelia Wiśniewska; Leszek Łankiewicz; Marcin Dyba
Journal:  J Inorg Biochem       Date:  2004-06       Impact factor: 4.155

10.  Copper, iron and zinc in Alzheimer's disease senile plaques.

Authors:  M A Lovell; J D Robertson; W J Teesdale; J L Campbell; W R Markesbery
Journal:  J Neurol Sci       Date:  1998-06-11       Impact factor: 3.181

View more
  17 in total

Review 1.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 2.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

3.  Iodide-doped precious metal nanoparticles: measuring oxidative stress in vivo via photoacoustic imaging.

Authors:  Yash Mantri; Barak Davidi; Jeanne E Lemaster; Ali Hariri; Jesse V Jokerst
Journal:  Nanoscale       Date:  2020-05-21       Impact factor: 7.790

4.  Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance.

Authors:  Elena Atrián-Blasco; Paulina Gonzalez; Alice Santoro; Bruno Alies; Peter Faller; Christelle Hureau
Journal:  Coord Chem Rev       Date:  2018-09-15       Impact factor: 22.315

5.  A Trishistidine Pseudopeptide with Ability to Remove Both CuΙ and CuΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation.

Authors:  Amandine Conte-Daban; Bastien Boff; Andreza Candido Matias; Claudia N Montes Aparicio; Christelle Gateau; Colette Lebrun; Giselle Cerchiaro; Isabelle Kieffer; Stéphanie Sayen; Emmanuel Guillon; Pascale Delangle; Christelle Hureau
Journal:  Chemistry       Date:  2017-11-09       Impact factor: 5.236

6.  His18 promotes reactive oxidative stress production in copper-ion mediated human islet amyloid polypeptide aggregation.

Authors:  Gengyang Huo; Wenyong Chen; Jianhua Wang; Xinxing Chu; Wei Xu; Bin Li; Yi Zhang; Binqian Xu; Xingfei Zhou
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 3.361

7.  Rational Design of a Cu Chelator That Mitigates Cu-Induced ROS Production by Amyloid Beta.

Authors:  Suchitra Mitra; Kallol Talukdar; Pallavi Prasad; Sandeep K Misra; Shabana Khan; Joshua S Sharp; Jonah W Jurss; Saumen Chakraborty
Journal:  Chembiochem       Date:  2021-12-30       Impact factor: 3.461

Review 8.  Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.

Authors:  Mattia Toni; Maria L Massimino; Agnese De Mario; Elisa Angiulli; Enzo Spisni
Journal:  Front Neurosci       Date:  2017-01-19       Impact factor: 4.677

9.  Ascorbate Oxidation by Cu(Amyloid-β) Complexes: Determination of the Intrinsic Rate as a Function of Alterations in the Peptide Sequence Revealing Key Residues for Reactive Oxygen Species Production.

Authors:  Elena Atrián-Blasco; Melisa Del Barrio; Peter Faller; Christelle Hureau
Journal:  Anal Chem       Date:  2018-04-12       Impact factor: 6.986

10.  Cu(II) binding to various forms of amyloid-β peptides. Are they friends or foes?

Authors:  Valentina Borghesani; Bruno Alies; Christelle Hureau
Journal:  Eur J Inorg Chem       Date:  2018-01-10       Impact factor: 2.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.